

COSRX-The Hyaluronic Acid 3 Serum 20ml
₨ 8,467 Original price was: ₨ 8,467.₨ 6,199Current price is: ₨ 6,199.
Replenish and plump your skin with COSRX The Hyaluronic Acid 3 Serum (20ml) — a concentrated formula featuring 3% hyaluronic acid, amino acids, and ceramides.
In stock
Description
COSRX The Hyaluronic Acid 3 Serum (20ml) is a high-performance hydrating serum designed to combat dryness and improve skin texture. Infused with 3% hyaluronic acid, it penetrates deeply to provide intense moisture, while a complex of amino acids (Natural Moisturizing Factors) and ceramides work synergistically to fortify the skin’s barrier and lock in hydration.
The lightweight, non-greasy texture absorbs quickly, making it suitable for all skin types, including sensitive and acne-prone skin. Regular use helps to alleviate flakiness, reduce the appearance of fine lines, and create a smooth, dewy complexion.
How to Use:
After cleansing, apply a few drops to the face during the serum phase. Gently massage into the skin until fully absorbed. Use morning and evening for optimal results.
Now available at BeAuthantic — your trusted destination for original Korean skincare.
Cash on Delivery available across Pakistan.
Additional information
Brand |
COSRX |
---|
Related products
Beauty of Joseon-Glow Deep Serum : Rice +Alpha Arbutin 30ml
In stock
COSRX-Acne Pimple Master 24 patches
In stock
COSRX-Advanced Snail 96 Mucin Power Essence 100ml
In stock
COSRX-Centella Water Alcohol-Free Toner 150ml
In stock
COSRX-Hyaluronic Acid Hydra Power Essence 100ml
In stock
COSRX-The Vitamin C 13 serum 20ml
In stock
The Ordinary-Caffeine Solution 5% + EGCG
In stock
The Ordinary Caffeine Solution 5% + EGCG is a lightweight eye serum designed to reduce the appearance of puffiness and dark circles. Infused with caffeine and EGCG (Epigallocatechin Gallatyl Glucoside), it helps to refresh and energize the skin around the eyes, leaving it looking more awake and revitalized
The Ordinary-Lactic Acid 5% + Hyaluronic Acid 2%
In stock
Reviews
There are no reviews yet.